Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.92% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CPIX · Sep 30, 2012
CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-12-449319General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.18% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-4.00% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
59.94% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
92.64% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
23.77% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
13.54% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.12% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 1.18%
- Current
- 0.92%
- Delta
- -0.27%
- Previous
- 5.13%
- Current
- 15.18%
- Delta
- 10.04%
- Previous
- -14.06%
- Current
- -4.00%
- Delta
- 10.05%
- Previous
- 59.16%
- Current
- 59.94%
- Delta
- 0.78%
- Previous
- 91.08%
- Current
- 92.64%
- Delta
- 1.56%
- Previous
- 15.69%
- Current
- 23.77%
- Delta
- 8.09%
- Previous
- 12.56%
- Current
- 13.54%
- Delta
- 0.98%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CPIX Fundamental State →Has State · CUMBERLAND PHARMACEUTICALS INC →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX CAPEX_INTENSITY_DECREASED →Transitioned To · CPIX CASH_GENERATION_INCREASED →Transitioned To · CPIX GROWTH_INCREASED →Transitioned To · CPIX INVENTORY_PRESSURE_INCREASED →Transitioned To · CPIX MARGIN_INCREASED →Transitioned To · CPIX PROFITABILITY_INCREASED →Transitioned To · CPIX R_AND_D_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.